PCSK9 inhibition: the way forward in the treatment of dyslipidemia

por Stoekenbroek, Robert M., Kastelein, John JP, Huijgen, Roeland
Publicado 2015

An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study

por Kallend, David, Mason, Jay, Smith, Patrick F., Koren, Michael J., Stoekenbroek, Robert, He, YanLing, Wijngaard, Peter
Publicado 2022

How common are foot problems among individuals with diabetes? Diabetic foot ulcers in the Dutch population

por Stoekenbroek, Robert M., Lokin, Joost L.C., Nielen, Mark M., Stroes, Erik S.G., Koelemay, Mark J.W.
Publicado 2017

Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study

por Bernelot Moens, Sophie J., Stoekenbroek, Robert M., van der Valk, Fleur M., Verweij, Simone L., Koelemay, Mark J. W., Verberne, Hein J., Nieuwdorp, Max, Stroes, Erik S. G.
Publicado 2016

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9

por Zeitlinger, Markus, Bauer, Martin, Reindl-Schwaighofer, Roman, Stoekenbroek, Robert M., Lambert, Gilles, Berger-Sieczkowski, Evelyn, Lagler, Heimo, Oesterreicher, Zoe, Wulkersdorfer, Beatrix, Lührs, Petra, Galabova, Gergana, Schwenke, Carsten, Mader, Robert M., Medori, Rossella, Landlinger, Christine, Kutzelnigg, Alexandra, Staffler, Günther
Publicado 2021